Avicena North America Inc. — Form D
Avicena North America Inc. of ALEXANDRIA, VA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-24. The offering totals $44.4M, of which $44.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-03-24
- Form: D
- Accession: 0001909215-22-000001
- Industry: Other Health Care
- Exemptions: 06b, 4a5
- Total offering: $44.4M
- Amount sold: $44.4M
- Minimum investment: $1K
- Investors: 3
- Date of first sale: 2022-03-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438794
Issuer
- Name: Avicena North America Inc.
- CIK: 0001909215
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 209 N PAYNE ST, ALEXANDRIA, VA, 22314
- Phone: 706-372-2124
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Anthony Fitzgerald | Director | West Perth, C3 |
| William Jackson | Director | Atlanta, GA |
| Paul Watt | Director | West Perth, C3 |
| William Jackson | Executive Officer | Atlanta, GA |
More